Hostname: page-component-77f85d65b8-8v9h9 Total loading time: 0 Render date: 2026-03-29T08:56:14.889Z Has data issue: false hasContentIssue false

International perspective on social cognition in schizophrenia: current stage and the next steps

Published online by Cambridge University Press:  15 January 2025

Silvia Corbera*
Affiliation:
Department of Psychological Science, Central Connecticut State University, New Britain, CT, USA
Matthew M. Kurtz
Affiliation:
Department of Psychology, Wesleyan University, Middletown, CT, USA
Amélie M. Achim
Affiliation:
Departement de psychiatrie and neurosciences, Université Laval, Canada VITAM – Centre de recherche en santé durable, Québec, CA Centre de Recherche CERVO, Brain Research Center, Québec, CA
Giulia Agostoni
Affiliation:
School of Psychology, Vita-Salute San Raffaele University, Milan, Italy Department of Clinical Neurosciences, IRCCS San Raffaele Hospital, Milan, Italy
Isabelle Amado
Affiliation:
Resource Centre in Ile de France for Cognitive Remediation and Psychosocial Rehabilitation (C3RP), GHU Paris Psychiatry Neurosciences, Paris, France
Michal Assaf
Affiliation:
Olin Neuropsychiatry Research Center, Hartford Hospital, Hartford, CT, USA Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA
Stefano Barlati
Affiliation:
School of Medicine, University of Brescia, Brescia, Italy
Margherita Bechi
Affiliation:
Department of Clinical Neurosciences, IRCCS San Raffaele Hospital, Milan, Italy
Roberto Cavallaro
Affiliation:
School of Psychology, Vita-Salute San Raffaele University, Milan, Italy Department of Clinical Neurosciences, IRCCS San Raffaele Hospital, Milan, Italy
Satoru Ikezawa
Affiliation:
Department of Psychiatry, International University of Health and Welfare Mita Hospital, Tokyo, Japan
Hiroki Okano
Affiliation:
Department of Psychiatry, National Center of Neurology and Psychiatry, Tokyo, Japan Fukushima Medical Centre of Mental Health, Fukushima, Japan
Ryo Okubo
Affiliation:
Department of Neuropsychiatry, National Hospital Organization, Obihiro Hospital, Obihiro, Japan
Rafael Penadés
Affiliation:
Hospital Clinic Barcelona, University of Barcelona, IDIBAPS, CIBERSAM, Spain
Takashi Uchino
Affiliation:
Faculty of Medicine, Toho University, Tokyo, Japan
Antonio Vita
Affiliation:
School of Medicine, University of Brescia, Brescia, Italy Department of Mental Health, Spedali Civili, Hospital Brescia, Brescia Italy
Yuji Yamada
Affiliation:
Department of Psychiatry, National Center of Neurology and Psychiatry, Tokyo, Japan
Morris D Bell
Affiliation:
Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA
*
Corresponding author: Silvia Corbera; Email: silviac@ccsu.edu

Abstract

In the last decades, research from cognitive science, clinical psychology, psychiatry, and social neuroscience has provided mounting evidence that several social cognitive abilities are impaired in people with schizophrenia and contribute to functional difficulties and poor clinical outcomes. Social dysfunction is a hallmark of the illness, and yet, social cognition is seldom assessed in clinical practice or targeted for treatment. In this article, 17 international experts, from three different continents and six countries with expertise in social cognition and social neuroscience in schizophrenia, convened several meetings to provide clinicians with a summary of the most recent international research on social cognition evaluation and treatment in schizophrenia, and to lay out primary recommendations and procedures that can be integrated into their practice. Given that many extant measures used to assess social cognition have been developed in North America or Western Europe, this article is also a call for researchers and clinicians to validate instruments internationally and we provide preliminary guidance for the adaptation and use of social cognitive measures in clinical and research evaluations internationally. This effort will assist promoting scientific rigor, enhanced clinical practice, and will help propel international scientific research and collaboration and patient care.

Information

Type
Review/Meta-analysis
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0), which permits non-commercial re-use, distribution, and reproduction in any medium, provided that no alterations are made and the original article is properly cited. The written permission of Cambridge University Press must be obtained prior to any commercial use and/or adaptation of the article.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of European Psychiatric Association
Figure 0

Table 1. Adaptation and expansion of the table of measures of social cognition in schizophrenia from Vita et al., 2022

Figure 1

Figure 1. Flowchart for the assessment and treatment of social cognition in schizophrenia.

Figure 2

Figure 2. Assessment of social cognitive deficits.Note.** Measures recommended by the SCOPE trial and Vita et al., 2022.* Measures considered by the SCOPE trial, but they did not show adequate psychometric properties. See Table 1 for a list of these clinical tools translated/adapted/validated to other languages.

Supplementary material: File

Corbera et al. supplementary material

Corbera et al. supplementary material
Download Corbera et al. supplementary material(File)
File 440.4 KB
Submit a response

Comments

No Comments have been published for this article.